CATHLEEN WORTHINGTON: Open Payments
NPI 1134842081 · MARGATE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$756 in 60 payments from 12 companies in 2025. Trend: 2023 $721 · 2024 $1,188 · 2025 $756
Food & beverage: $756
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 19 | $209 |
| ABBVIE INC. | 16 | $170 |
| Otsuka America Pharmaceutical, Inc. | 15 | $169 |
| SANOFI-AVENTIS U.S. LLC | 1 | $45 |
| Lundbeck LLC | 2 | $35 |
| Novo Nordisk Inc | 1 | $28 |
| Phadia US Inc. | 1 | $21 |
| PFIZER INC. | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: REXULTI, OTEZLA, VRAYLAR, TZIELD, REPATHA, UBRELVY, Ozempic, ImmunoCAP.
Industry payments across NJ — which companies pay providers there.
